ROCK

Welcome to the Brand page for “ROCK”, which is offered here for In the statement, page 2 line 2, reg. no. 01706865 should be deleted, and reg. no. 017068685 should be inserted.;pharmaceutical and veterinary preparations; biological and biochemical preparations in form of antibodies, antibody derivatives, binding proteins and peptides for medical or veterinary purposes; biological and biochemical preparations in form of bifunctional or multifunctional proteins with binding affinity to immune cells, in particular with binding affinity to t cells and natural killer (nk) cells, in particular for the subsequent targeting of cancer cells; biological and biochemical preparations for diagnostic and therapeutic use, in particular in form of antibodies, antibody derivatives, binding proteins and peptides; biological and biochemical preparations in form of antibodies, antibody derivatives, binding proteins and peptides for use within the framework of experimental and medical or veterinary assays;biological and biochemical preparations, in particular in form of antibodies, antibody derivatives, binding proteins and peptides for laboratory and experimentation purposes, in particular for conducting experimental assays, other than for medical or veterinary purposes;medical services, in particular in the field of immunotherapy, in particular in the field of immuno-oncology; medical services in the field of virology; medical services in the field of antiinfectives; medical services in the field of neurodegenerative diseases; medical services in the field of autoimmune diseases; in particular all of the aforesaid services related to the use of antibodies, antibody derivatives, binding proteins and peptides; medical services in the field of immunotherapy by means of activating or modulating innate and adaptive immunity, in particular in the field of immuno-oncology;scientific and technological services, research and design in the field of immuno-therapy, in particular in the field of immuno-oncology; scientific and technological services, research and design in the field of virology; scientific and technological services, research and design in the field of antiinfectives; scientific and technological services, research and design in the field of neurodegenerative diseases; scientific and technological services, research and design in the field of autoimmune diseases; in particular all of the aforesaid services related to the use of antibodies, antibody derivatives, binding proteins and peptides; scientific and technological services, research and design in the field of immunotherapy by means of activating or modulating innate and adaptive immunity, in particular in the field of immune-oncology; industrial analysis and research services;.

Its status is currently believed to be active. Its class is unavailable. “ROCK” is believed to be currently owned by “Affimed GmbH”.